| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrolases | 65 | 2024 | 82 | 11.830 |
Why?
|
| Protein-Arginine Deiminases | 76 | 2026 | 91 | 9.030 |
Why?
|
| Enzyme Inhibitors | 42 | 2026 | 367 | 7.930 |
Why?
|
| Citrulline | 40 | 2025 | 46 | 7.830 |
Why?
|
| Citrullination | 30 | 2025 | 38 | 7.700 |
Why?
|
| Arginine | 23 | 2025 | 136 | 4.840 |
Why?
|
| Amidines | 17 | 2021 | 19 | 4.380 |
Why?
|
| Protein-Arginine N-Methyltransferases | 13 | 2014 | 35 | 4.060 |
Why?
|
| Protein Processing, Post-Translational | 29 | 2025 | 268 | 4.020 |
Why?
|
| Armadillo Domain Proteins | 5 | 2023 | 27 | 2.770 |
Why?
|
| Histones | 30 | 2025 | 494 | 2.640 |
Why?
|
| NAD | 6 | 2023 | 54 | 2.460 |
Why?
|
| Proteomics | 11 | 2025 | 293 | 2.340 |
Why?
|
| Molecular Probes | 6 | 2026 | 34 | 2.320 |
Why?
|
| Ornithine | 22 | 2021 | 24 | 2.270 |
Why?
|
| Proteins | 11 | 2024 | 764 | 2.250 |
Why?
|
| Arthritis, Rheumatoid | 16 | 2023 | 346 | 2.230 |
Why?
|
| Cytoskeletal Proteins | 5 | 2023 | 204 | 2.060 |
Why?
|
| Calcium | 12 | 2025 | 584 | 1.880 |
Why?
|
| Extracellular Traps | 12 | 2025 | 45 | 1.830 |
Why?
|
| Kinetics | 24 | 2020 | 760 | 1.790 |
Why?
|
| Nicotinamide N-Methyltransferase | 3 | 2019 | 3 | 1.730 |
Why?
|
| Catalysis | 19 | 2021 | 164 | 1.680 |
Why?
|
| Animals | 81 | 2026 | 21345 | 1.520 |
Why?
|
| Humans | 123 | 2026 | 65140 | 1.490 |
Why?
|
| Repressor Proteins | 7 | 2020 | 351 | 1.440 |
Why?
|
| Membrane Proteins | 4 | 2026 | 919 | 1.430 |
Why?
|
| Molecular Structure | 13 | 2025 | 316 | 1.330 |
Why?
|
| Methylation | 14 | 2019 | 130 | 1.310 |
Why?
|
| Caenorhabditis elegans Proteins | 5 | 2022 | 447 | 1.310 |
Why?
|
| Wallerian Degeneration | 2 | 2020 | 8 | 1.270 |
Why?
|
| Axons | 4 | 2023 | 124 | 1.260 |
Why?
|
| Caenorhabditis elegans | 6 | 2023 | 706 | 1.250 |
Why?
|
| Benzimidazoles | 4 | 2018 | 56 | 1.230 |
Why?
|
| Cysteine | 6 | 2021 | 108 | 1.210 |
Why?
|
| Acetamides | 2 | 2026 | 17 | 1.200 |
Why?
|
| Substrate Specificity | 18 | 2021 | 341 | 1.200 |
Why?
|
| Peptides | 11 | 2021 | 591 | 1.190 |
Why?
|
| Mice | 54 | 2026 | 11119 | 1.140 |
Why?
|
| Nucleotidyltransferases | 3 | 2026 | 66 | 1.130 |
Why?
|
| Drug Design | 7 | 2021 | 137 | 1.110 |
Why?
|
| Antineoplastic Agents | 8 | 2023 | 643 | 1.090 |
Why?
|
| Chlorides | 2 | 2020 | 33 | 1.070 |
Why?
|
| Epigenesis, Genetic | 6 | 2023 | 407 | 1.070 |
Why?
|
| Bacterial Proteins | 4 | 2016 | 742 | 1.060 |
Why?
|
| Fluorescent Dyes | 7 | 2017 | 202 | 1.040 |
Why?
|
| Structure-Activity Relationship | 9 | 2026 | 355 | 1.040 |
Why?
|
| Niacinamide | 4 | 2020 | 33 | 1.020 |
Why?
|
| Models, Molecular | 15 | 2021 | 1162 | 1.020 |
Why?
|
| Triazoles | 2 | 2025 | 63 | 0.980 |
Why?
|
| HEK293 Cells | 11 | 2021 | 616 | 0.970 |
Why?
|
| Alkynes | 1 | 2026 | 28 | 0.940 |
Why?
|
| Amino Acid Sequence | 17 | 2021 | 1589 | 0.940 |
Why?
|
| Amides | 1 | 2026 | 60 | 0.930 |
Why?
|
| Adenosine Triphosphate | 4 | 2022 | 301 | 0.880 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 2016 | 42 | 0.880 |
Why?
|
| Catalytic Domain | 10 | 2023 | 201 | 0.870 |
Why?
|
| Enzyme Activation | 10 | 2021 | 391 | 0.850 |
Why?
|
| Hydrocarbons, Fluorinated | 3 | 2011 | 12 | 0.840 |
Why?
|
| Mutagenesis, Site-Directed | 7 | 2018 | 251 | 0.830 |
Why?
|
| Neurodegenerative Diseases | 3 | 2022 | 152 | 0.820 |
Why?
|
| Amyotrophic Lateral Sclerosis | 3 | 2024 | 515 | 0.820 |
Why?
|
| Small Molecule Libraries | 4 | 2024 | 57 | 0.810 |
Why?
|
| Nicotinamide Mononucleotide | 1 | 2023 | 2 | 0.810 |
Why?
|
| Isoenzymes | 10 | 2024 | 130 | 0.810 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2023 | 13 | 0.790 |
Why?
|
| Thrombosis | 2 | 2023 | 206 | 0.780 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2021 | 138 | 0.780 |
Why?
|
| High-Throughput Screening Assays | 4 | 2024 | 79 | 0.760 |
Why?
|
| Nicotinamide-Nucleotide Adenylyltransferase | 1 | 2022 | 1 | 0.750 |
Why?
|
| S-Adenosylmethionine | 3 | 2018 | 31 | 0.740 |
Why?
|
| NAD+ Nucleosidase | 2 | 2022 | 10 | 0.740 |
Why?
|
| Hepatitis C, Chronic | 1 | 2022 | 89 | 0.700 |
Why?
|
| Plasminogen Inactivators | 1 | 2021 | 1 | 0.700 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2021 | 10 | 0.700 |
Why?
|
| Antifibrinolytic Agents | 1 | 2021 | 19 | 0.690 |
Why?
|
| Citric Acid | 1 | 2021 | 20 | 0.690 |
Why?
|
| Protein Interaction Mapping | 1 | 2021 | 69 | 0.690 |
Why?
|
| Antithrombins | 1 | 2021 | 16 | 0.690 |
Why?
|
| Phase Transition | 1 | 2021 | 23 | 0.680 |
Why?
|
| Data Mining | 1 | 2021 | 38 | 0.680 |
Why?
|
| Neutrophils | 8 | 2023 | 395 | 0.660 |
Why?
|
| Berberine | 1 | 2020 | 4 | 0.650 |
Why?
|
| Zinc Compounds | 1 | 2020 | 7 | 0.650 |
Why?
|
| Venous Thrombosis | 1 | 2021 | 112 | 0.640 |
Why?
|
| Mammals | 2 | 2022 | 222 | 0.630 |
Why?
|
| Oxidative Stress | 3 | 2016 | 321 | 0.610 |
Why?
|
| Phenylalanine | 3 | 2021 | 25 | 0.610 |
Why?
|
| Cell Line, Tumor | 18 | 2025 | 1565 | 0.600 |
Why?
|
| Molecular Sequence Data | 11 | 2015 | 1979 | 0.600 |
Why?
|
| Neuroprotective Agents | 1 | 2019 | 78 | 0.590 |
Why?
|
| Thioredoxins | 1 | 2019 | 17 | 0.590 |
Why?
|
| Protein Binding | 9 | 2021 | 1640 | 0.580 |
Why?
|
| Recombinant Proteins | 9 | 2021 | 710 | 0.580 |
Why?
|
| Photochemical Processes | 2 | 2018 | 18 | 0.570 |
Why?
|
| Drug Discovery | 5 | 2024 | 96 | 0.550 |
Why?
|
| Cell Nucleus | 4 | 2023 | 630 | 0.540 |
Why?
|
| Macrophages | 8 | 2025 | 1038 | 0.540 |
Why?
|
| Antibodies | 2 | 2015 | 187 | 0.530 |
Why?
|
| Receptor Cross-Talk | 1 | 2017 | 10 | 0.520 |
Why?
|
| Staining and Labeling | 1 | 2018 | 127 | 0.510 |
Why?
|
| Vibrio parahaemolyticus | 2 | 2013 | 2 | 0.500 |
Why?
|
| Protein Conformation | 7 | 2021 | 792 | 0.500 |
Why?
|
| Cell Line | 8 | 2023 | 2024 | 0.500 |
Why?
|
| Streptonigrin | 2 | 2014 | 3 | 0.500 |
Why?
|
| Sulfur Oxides | 1 | 2016 | 1 | 0.500 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2025 | 856 | 0.490 |
Why?
|
| Transcription, Genetic | 3 | 2017 | 907 | 0.480 |
Why?
|
| Antiviral Agents | 4 | 2023 | 321 | 0.470 |
Why?
|
| Organophosphonates | 1 | 2015 | 22 | 0.460 |
Why?
|
| Biocatalysis | 4 | 2021 | 50 | 0.460 |
Why?
|
| Antibody Specificity | 1 | 2015 | 102 | 0.460 |
Why?
|
| Autoimmune Diseases | 5 | 2021 | 239 | 0.460 |
Why?
|
| Binding Sites | 7 | 2020 | 921 | 0.450 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2020 | 583 | 0.440 |
Why?
|
| Tetrazoles | 1 | 2015 | 22 | 0.440 |
Why?
|
| Phosphorylation | 7 | 2024 | 962 | 0.440 |
Why?
|
| Proteome | 3 | 2025 | 152 | 0.440 |
Why?
|
| Ruthenium Red | 1 | 2014 | 3 | 0.420 |
Why?
|
| Molecular Docking Simulation | 3 | 2022 | 81 | 0.410 |
Why?
|
| Combinatorial Chemistry Techniques | 2 | 2011 | 8 | 0.410 |
Why?
|
| Adenosine Monophosphate | 1 | 2013 | 29 | 0.400 |
Why?
|
| Cell Differentiation | 7 | 2024 | 1386 | 0.400 |
Why?
|
| Pluripotent Stem Cells | 1 | 2014 | 72 | 0.400 |
Why?
|
| Tyrosine | 1 | 2014 | 93 | 0.400 |
Why?
|
| Lectins | 2 | 2011 | 43 | 0.400 |
Why?
|
| Bacillus | 1 | 2013 | 14 | 0.400 |
Why?
|
| Ovarian Neoplasms | 2 | 2025 | 166 | 0.390 |
Why?
|
| Arthritis, Experimental | 5 | 2016 | 30 | 0.390 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2022 | 137 | 0.380 |
Why?
|
| Mass Spectrometry | 5 | 2019 | 295 | 0.380 |
Why?
|
| Phenylglyoxal | 1 | 2012 | 1 | 0.380 |
Why?
|
| Helicobacter pylori | 2 | 2010 | 58 | 0.380 |
Why?
|
| Acute Lung Injury | 2 | 2025 | 45 | 0.380 |
Why?
|
| Hydrogen-Ion Concentration | 6 | 2017 | 464 | 0.370 |
Why?
|
| Mice, Inbred C57BL | 15 | 2025 | 3485 | 0.370 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2014 | 160 | 0.370 |
Why?
|
| Crystallography, X-Ray | 6 | 2021 | 419 | 0.370 |
Why?
|
| Signal Transduction | 8 | 2025 | 3153 | 0.370 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2012 | 23 | 0.360 |
Why?
|
| Neoplasms | 5 | 2021 | 1368 | 0.350 |
Why?
|
| Peptide Hydrolases | 2 | 2022 | 79 | 0.350 |
Why?
|
| Imines | 1 | 2011 | 4 | 0.340 |
Why?
|
| Disease Models, Animal | 10 | 2022 | 2293 | 0.340 |
Why?
|
| Protons | 2 | 2010 | 67 | 0.340 |
Why?
|
| Boronic Acids | 1 | 2011 | 28 | 0.340 |
Why?
|
| Lupus Erythematosus, Systemic | 4 | 2018 | 183 | 0.330 |
Why?
|
| Protease Inhibitors | 2 | 2022 | 106 | 0.330 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2011 | 86 | 0.330 |
Why?
|
| MicroRNAs | 4 | 2023 | 713 | 0.320 |
Why?
|
| Protein Kinases | 1 | 2011 | 153 | 0.320 |
Why?
|
| Drug Delivery Systems | 1 | 2014 | 333 | 0.320 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 2 | 2023 | 161 | 0.320 |
Why?
|
| Glycoproteins | 1 | 2011 | 189 | 0.310 |
Why?
|
| Apoptosis | 10 | 2019 | 1098 | 0.310 |
Why?
|
| Neoplastic Stem Cells | 2 | 2025 | 195 | 0.300 |
Why?
|
| Gene Expression Regulation | 8 | 2021 | 1630 | 0.300 |
Why?
|
| Uterus | 2 | 2021 | 41 | 0.290 |
Why?
|
| Acetyltransferases | 4 | 2013 | 27 | 0.290 |
Why?
|
| DNA | 3 | 2025 | 858 | 0.290 |
Why?
|
| Sepsis | 2 | 2024 | 296 | 0.280 |
Why?
|
| Models, Chemical | 3 | 2019 | 137 | 0.280 |
Why?
|
| Enzyme Assays | 2 | 2020 | 13 | 0.280 |
Why?
|
| Immunologic Factors | 1 | 2009 | 110 | 0.280 |
Why?
|
| Breast Neoplasms | 5 | 2019 | 1222 | 0.280 |
Why?
|
| Nuclear Proteins | 2 | 2016 | 790 | 0.280 |
Why?
|
| Deoxyadenosines | 1 | 2008 | 3 | 0.280 |
Why?
|
| Cell Survival | 4 | 2021 | 587 | 0.270 |
Why?
|
| Epidermis | 2 | 2019 | 35 | 0.270 |
Why?
|
| Multiple Sclerosis | 3 | 2020 | 226 | 0.270 |
Why?
|
| Methionine | 2 | 2012 | 57 | 0.270 |
Why?
|
| Mammary Glands, Animal | 2 | 2020 | 76 | 0.260 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2025 | 217 | 0.260 |
Why?
|
| Soot | 2 | 2021 | 8 | 0.260 |
Why?
|
| Lactation | 2 | 2020 | 78 | 0.260 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 801 | 0.260 |
Why?
|
| Chromatin | 4 | 2023 | 641 | 0.260 |
Why?
|
| Drug Evaluation, Preclinical | 4 | 2024 | 95 | 0.260 |
Why?
|
| Inhibitory Concentration 50 | 4 | 2021 | 52 | 0.250 |
Why?
|
| Oxidation-Reduction | 3 | 2019 | 326 | 0.250 |
Why?
|
| Antirheumatic Agents | 1 | 2009 | 227 | 0.250 |
Why?
|
| Th17 Cells | 4 | 2019 | 63 | 0.250 |
Why?
|
| Disease | 2 | 2019 | 26 | 0.240 |
Why?
|
| Female | 27 | 2025 | 34018 | 0.240 |
Why?
|
| Bacillus subtilis | 2 | 2016 | 28 | 0.240 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 129 | 0.240 |
Why?
|
| MAP Kinase Kinase 1 | 2 | 2023 | 16 | 0.240 |
Why?
|
| Pyroptosis | 3 | 2020 | 38 | 0.230 |
Why?
|
| Dendritic Cells | 3 | 2018 | 531 | 0.230 |
Why?
|
| Transcriptional Activation | 3 | 2017 | 197 | 0.230 |
Why?
|
| Autoimmunity | 3 | 2018 | 247 | 0.230 |
Why?
|
| Type C Phospholipases | 1 | 2025 | 34 | 0.220 |
Why?
|
| RNA, Messenger | 7 | 2023 | 1574 | 0.220 |
Why?
|
| Transcription Factor RelA | 1 | 2025 | 51 | 0.220 |
Why?
|
| Immunoprecipitation | 3 | 2014 | 128 | 0.220 |
Why?
|
| Organophosphorus Compounds | 2 | 2015 | 33 | 0.210 |
Why?
|
| Pyruvate Kinase | 1 | 2024 | 11 | 0.210 |
Why?
|
| CD24 Antigen | 1 | 2024 | 18 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2025 | 215 | 0.210 |
Why?
|
| Histidine | 2 | 2019 | 36 | 0.210 |
Why?
|
| Acyltransferases | 1 | 2024 | 33 | 0.210 |
Why?
|
| Anthelmintics | 1 | 2024 | 47 | 0.210 |
Why?
|
| Cells, Cultured | 8 | 2021 | 2188 | 0.200 |
Why?
|
| Interferon Type I | 2 | 2023 | 196 | 0.200 |
Why?
|
| Tamoxifen | 2 | 2023 | 42 | 0.200 |
Why?
|
| Myoblasts | 1 | 2024 | 64 | 0.200 |
Why?
|
| Cyclic GMP | 1 | 2023 | 33 | 0.200 |
Why?
|
| Herpes Simplex | 1 | 2023 | 49 | 0.200 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2013 | 318 | 0.200 |
Why?
|
| Drug Synergism | 3 | 2017 | 142 | 0.200 |
Why?
|
| Virus Replication | 2 | 2023 | 323 | 0.200 |
Why?
|
| Inflammation | 3 | 2020 | 1192 | 0.190 |
Why?
|
| Herpesvirus 1, Human | 1 | 2023 | 83 | 0.190 |
Why?
|
| Cathepsin L | 1 | 2022 | 21 | 0.190 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2022 | 7 | 0.190 |
Why?
|
| Epithelial Cells | 4 | 2021 | 413 | 0.190 |
Why?
|
| Uremia | 1 | 2022 | 9 | 0.190 |
Why?
|
| Phagocytosis | 1 | 2024 | 257 | 0.190 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2024 | 182 | 0.190 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2022 | 25 | 0.190 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 203 | 0.190 |
Why?
|
| Kanamycin Kinase | 1 | 2002 | 3 | 0.190 |
Why?
|
| Actins | 1 | 2024 | 264 | 0.190 |
Why?
|
| Phosphorus | 1 | 2002 | 16 | 0.190 |
Why?
|
| Inflammasomes | 3 | 2025 | 352 | 0.190 |
Why?
|
| Lipopolysaccharides | 3 | 2020 | 625 | 0.180 |
Why?
|
| Fibroblasts | 2 | 2021 | 422 | 0.180 |
Why?
|
| Blood Platelets | 2 | 2022 | 108 | 0.180 |
Why?
|
| Biology | 1 | 2022 | 25 | 0.180 |
Why?
|
| Th2 Cells | 2 | 2019 | 93 | 0.180 |
Why?
|
| Nucleotides | 1 | 2002 | 48 | 0.180 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2023 | 144 | 0.180 |
Why?
|
| Th1 Cells | 3 | 2018 | 171 | 0.180 |
Why?
|
| Serine | 1 | 2002 | 90 | 0.180 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2022 | 94 | 0.180 |
Why?
|
| Pyrrolidinones | 1 | 2021 | 11 | 0.180 |
Why?
|
| Transcription Factors | 5 | 2024 | 1556 | 0.180 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2021 | 23 | 0.180 |
Why?
|
| Valine | 1 | 2021 | 32 | 0.170 |
Why?
|
| Isoxazoles | 1 | 2021 | 15 | 0.170 |
Why?
|
| Elastic Tissue | 1 | 2021 | 5 | 0.170 |
Why?
|
| Limit of Detection | 2 | 2012 | 49 | 0.170 |
Why?
|
| Gonadotropin-Releasing Hormone | 2 | 2024 | 88 | 0.170 |
Why?
|
| RNA, Viral | 1 | 2022 | 266 | 0.170 |
Why?
|
| Ultraviolet Rays | 2 | 2021 | 147 | 0.170 |
Why?
|
| Cadmium | 1 | 2021 | 12 | 0.170 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2021 | 38 | 0.170 |
Why?
|
| Vimentin | 1 | 2021 | 19 | 0.170 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 2 | 2021 | 6 | 0.170 |
Why?
|
| Cell Proliferation | 5 | 2019 | 1038 | 0.170 |
Why?
|
| Autoantibodies | 4 | 2014 | 184 | 0.160 |
Why?
|
| Doxorubicin | 2 | 2011 | 98 | 0.160 |
Why?
|
| Dimethyl Fumarate | 1 | 2020 | 8 | 0.160 |
Why?
|
| Familial Mediterranean Fever | 1 | 2020 | 9 | 0.160 |
Why?
|
| Cytomegalovirus | 1 | 2021 | 94 | 0.160 |
Why?
|
| Progesterone | 1 | 2021 | 165 | 0.160 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2020 | 20 | 0.160 |
Why?
|
| Mutation | 4 | 2019 | 2661 | 0.160 |
Why?
|
| Immunity, Innate | 2 | 2018 | 827 | 0.160 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 2020 | 16 | 0.160 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2020 | 59 | 0.160 |
Why?
|
| Pancreas | 1 | 2020 | 154 | 0.160 |
Why?
|
| Milk Proteins | 1 | 2020 | 45 | 0.160 |
Why?
|
| Mutagenesis | 1 | 2020 | 133 | 0.160 |
Why?
|
| Amino Acid Motifs | 1 | 2020 | 156 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 3 | 2013 | 676 | 0.150 |
Why?
|
| Autophagy | 2 | 2019 | 237 | 0.150 |
Why?
|
| Male | 15 | 2025 | 31047 | 0.150 |
Why?
|
| von Willebrand Factor | 1 | 2019 | 10 | 0.150 |
Why?
|
| Extracellular Vesicles | 1 | 2020 | 46 | 0.150 |
Why?
|
| Shock, Septic | 1 | 2020 | 89 | 0.150 |
Why?
|
| Neurons | 2 | 2023 | 933 | 0.150 |
Why?
|
| Green Fluorescent Proteins | 1 | 2021 | 372 | 0.150 |
Why?
|
| Multiprotein Complexes | 2 | 2024 | 156 | 0.150 |
Why?
|
| Vascular System Injuries | 1 | 2019 | 22 | 0.150 |
Why?
|
| Protein Domains | 1 | 2020 | 154 | 0.150 |
Why?
|
| Molecular Probe Techniques | 1 | 2019 | 6 | 0.150 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2019 | 66 | 0.150 |
Why?
|
| Aspartic Acid | 1 | 2019 | 34 | 0.150 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2019 | 115 | 0.140 |
Why?
|
| Cell Movement | 2 | 2020 | 482 | 0.140 |
Why?
|
| Somatotrophs | 1 | 2018 | 2 | 0.140 |
Why?
|
| Lactotrophs | 1 | 2018 | 2 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2014 | 663 | 0.140 |
Why?
|
| Embryo, Mammalian | 1 | 2019 | 158 | 0.140 |
Why?
|
| Biotin | 2 | 2025 | 54 | 0.140 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2019 | 223 | 0.140 |
Why?
|
| Pharmacology | 1 | 2018 | 4 | 0.140 |
Why?
|
| Azo Compounds | 1 | 2018 | 7 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 345 | 0.140 |
Why?
|
| Fluoroacetates | 1 | 2018 | 1 | 0.140 |
Why?
|
| Isomerism | 1 | 2018 | 29 | 0.140 |
Why?
|
| Oncogenes | 1 | 2018 | 70 | 0.140 |
Why?
|
| Ammonia | 2 | 2010 | 16 | 0.140 |
Why?
|
| Technology, Pharmaceutical | 1 | 2018 | 20 | 0.140 |
Why?
|
| Click Chemistry | 1 | 2018 | 10 | 0.140 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2018 | 14 | 0.140 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2018 | 29 | 0.140 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2018 | 104 | 0.140 |
Why?
|
| Embryonic Development | 2 | 2016 | 142 | 0.140 |
Why?
|
| Calcium Signaling | 1 | 2019 | 164 | 0.130 |
Why?
|
| Adaptive Immunity | 1 | 2018 | 105 | 0.130 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2018 | 53 | 0.130 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 274 | 0.130 |
Why?
|
| Lysine | 3 | 2025 | 94 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 450 | 0.130 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2018 | 73 | 0.130 |
Why?
|
| Cell-Derived Microparticles | 1 | 2017 | 6 | 0.130 |
Why?
|
| Maleimides | 1 | 2017 | 9 | 0.130 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2017 | 17 | 0.130 |
Why?
|
| Intermediate Filament Proteins | 1 | 2017 | 19 | 0.130 |
Why?
|
| Humidity | 1 | 2017 | 12 | 0.130 |
Why?
|
| Cross-Linking Reagents | 2 | 2017 | 118 | 0.130 |
Why?
|
| Keratins | 1 | 2017 | 31 | 0.130 |
Why?
|
| N-Terminal Acetyltransferases | 1 | 2017 | 1 | 0.130 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 2017 | 4 | 0.130 |
Why?
|
| Immune Tolerance | 1 | 2018 | 183 | 0.130 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2017 | 55 | 0.130 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2017 | 27 | 0.130 |
Why?
|
| Dermatitis, Atopic | 1 | 2017 | 29 | 0.130 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2016 | 3 | 0.130 |
Why?
|
| Insulin | 1 | 2020 | 695 | 0.130 |
Why?
|
| Gonadotrophs | 1 | 2016 | 5 | 0.120 |
Why?
|
| Geobacillus stearothermophilus | 1 | 2016 | 1 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2021 | 440 | 0.120 |
Why?
|
| Indoles | 1 | 2017 | 112 | 0.120 |
Why?
|
| Amino Acids | 2 | 2022 | 148 | 0.120 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2017 | 71 | 0.120 |
Why?
|
| Neutrophil Activation | 1 | 2016 | 23 | 0.120 |
Why?
|
| Colonic Neoplasms | 2 | 2015 | 220 | 0.120 |
Why?
|
| Exosomes | 1 | 2017 | 54 | 0.120 |
Why?
|
| Protein Isoforms | 2 | 2014 | 201 | 0.120 |
Why?
|
| Molecular Conformation | 1 | 2016 | 115 | 0.120 |
Why?
|
| E2F1 Transcription Factor | 1 | 2016 | 18 | 0.120 |
Why?
|
| Algorithms | 1 | 2021 | 1050 | 0.120 |
Why?
|
| Haptens | 1 | 2015 | 14 | 0.120 |
Why?
|
| Neoplasm Proteins | 2 | 2020 | 285 | 0.120 |
Why?
|
| HL-60 Cells | 2 | 2016 | 18 | 0.120 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 464 | 0.120 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2015 | 44 | 0.120 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2016 | 247 | 0.110 |
Why?
|
| In Vitro Techniques | 3 | 2017 | 491 | 0.110 |
Why?
|
| Mice, Transgenic | 4 | 2022 | 1290 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2020 | 630 | 0.110 |
Why?
|
| Models, Theoretical | 1 | 2017 | 274 | 0.110 |
Why?
|
| Disease Progression | 4 | 2022 | 1220 | 0.110 |
Why?
|
| Nicotine | 1 | 2016 | 118 | 0.110 |
Why?
|
| Sf9 Cells | 1 | 2014 | 8 | 0.110 |
Why?
|
| Gene Expression | 4 | 2020 | 852 | 0.110 |
Why?
|
| Spodoptera | 1 | 2014 | 27 | 0.110 |
Why?
|
| Deuterium Exchange Measurement | 1 | 2015 | 19 | 0.110 |
Why?
|
| Colitis, Ulcerative | 1 | 2015 | 76 | 0.110 |
Why?
|
| Allosteric Regulation | 1 | 2014 | 71 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2015 | 364 | 0.110 |
Why?
|
| Lipoproteins, HDL | 1 | 2014 | 35 | 0.110 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2014 | 11 | 0.110 |
Why?
|
| Apoptosis Inducing Factor | 1 | 2014 | 4 | 0.100 |
Why?
|
| Solvents | 1 | 2014 | 60 | 0.100 |
Why?
|
| Pseudomonas Infections | 2 | 2025 | 73 | 0.100 |
Why?
|
| Cellular Reprogramming | 1 | 2014 | 41 | 0.100 |
Why?
|
| Colitis | 2 | 2015 | 77 | 0.100 |
Why?
|
| Coenzyme A | 2 | 2004 | 5 | 0.100 |
Why?
|
| Vibrio Infections | 1 | 2013 | 3 | 0.100 |
Why?
|
| MCF-7 Cells | 3 | 2019 | 65 | 0.100 |
Why?
|
| K562 Cells | 1 | 2014 | 58 | 0.100 |
Why?
|
| Benzophenones | 1 | 2014 | 20 | 0.100 |
Why?
|
| Quinolines | 1 | 2014 | 47 | 0.100 |
Why?
|
| Neural Stem Cells | 1 | 2014 | 47 | 0.100 |
Why?
|
| Biological Assay | 1 | 2014 | 56 | 0.100 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2019 | 203 | 0.100 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2025 | 132 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 604 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2014 | 83 | 0.100 |
Why?
|
| Gliosis | 2 | 2024 | 27 | 0.100 |
Why?
|
| Myelin Proteins | 2 | 2024 | 30 | 0.100 |
Why?
|
| Pneumonia | 1 | 2016 | 291 | 0.100 |
Why?
|
| Cytokines | 4 | 2020 | 952 | 0.100 |
Why?
|
| Protein Aggregates | 2 | 2024 | 24 | 0.100 |
Why?
|
| Amino Acid Substitution | 1 | 2014 | 238 | 0.100 |
Why?
|
| Myelin Sheath | 2 | 2024 | 38 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2010 | 58 | 0.100 |
Why?
|
| Antioxidants | 1 | 2015 | 249 | 0.100 |
Why?
|
| Kidney Diseases | 1 | 2014 | 177 | 0.090 |
Why?
|
| Rhodamines | 1 | 2012 | 20 | 0.090 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2013 | 47 | 0.090 |
Why?
|
| Genome, Human | 2 | 2012 | 237 | 0.090 |
Why?
|
| Estrogen Receptor alpha | 1 | 2012 | 49 | 0.090 |
Why?
|
| Mice, Nude | 3 | 2019 | 286 | 0.090 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2014 | 236 | 0.090 |
Why?
|
| Atherosclerosis | 1 | 2014 | 163 | 0.090 |
Why?
|
| Spinal Cord | 2 | 2024 | 209 | 0.090 |
Why?
|
| Biomarkers | 2 | 2020 | 1480 | 0.090 |
Why?
|
| Carbon | 1 | 2012 | 52 | 0.090 |
Why?
|
| Biotinylation | 1 | 2011 | 36 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 5 | 2016 | 687 | 0.090 |
Why?
|
| Silicon Dioxide | 1 | 2012 | 63 | 0.090 |
Why?
|
| Blastocyst | 1 | 2012 | 74 | 0.090 |
Why?
|
| Consensus Sequence | 1 | 2011 | 30 | 0.090 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2011 | 5 | 0.090 |
Why?
|
| Spinal Cord Regeneration | 1 | 2011 | 1 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2011 | 52 | 0.090 |
Why?
|
| Histone Deacetylase 1 | 1 | 2011 | 19 | 0.080 |
Why?
|
| Guanidine | 1 | 2011 | 24 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 3 | 2019 | 868 | 0.080 |
Why?
|
| Acetylation | 3 | 2017 | 121 | 0.080 |
Why?
|
| Gastrointestinal Agents | 1 | 2011 | 26 | 0.080 |
Why?
|
| Protein Array Analysis | 1 | 2011 | 26 | 0.080 |
Why?
|
| Streptococcus mutans | 1 | 2010 | 4 | 0.080 |
Why?
|
| Porphyromonas gingivalis | 1 | 2010 | 17 | 0.080 |
Why?
|
| Mice, Inbred DBA | 3 | 2016 | 84 | 0.080 |
Why?
|
| Biological Availability | 1 | 2011 | 209 | 0.080 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2010 | 26 | 0.080 |
Why?
|
| Fluorescence Polarization | 1 | 2010 | 32 | 0.080 |
Why?
|
| Viral Proteins | 2 | 2023 | 270 | 0.080 |
Why?
|
| Spinal Cord Injuries | 1 | 2011 | 54 | 0.080 |
Why?
|
| Peptide Library | 1 | 2010 | 33 | 0.080 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2010 | 37 | 0.080 |
Why?
|
| Peroxidase | 2 | 2025 | 70 | 0.080 |
Why?
|
| Acids | 1 | 2010 | 14 | 0.080 |
Why?
|
| Agmatine | 1 | 2009 | 3 | 0.080 |
Why?
|
| Epigenomics | 1 | 2010 | 62 | 0.080 |
Why?
|
| Nanostructures | 1 | 2012 | 188 | 0.080 |
Why?
|
| Colon | 1 | 2011 | 147 | 0.080 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 89 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 166 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2012 | 524 | 0.070 |
Why?
|
| Cardiovascular Diseases | 2 | 2014 | 863 | 0.070 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 380 | 0.070 |
Why?
|
| Sheep | 2 | 2021 | 189 | 0.070 |
Why?
|
| Lung | 3 | 2021 | 966 | 0.070 |
Why?
|
| Blotting, Western | 3 | 2016 | 611 | 0.070 |
Why?
|
| RNA-Binding Proteins | 2 | 2023 | 447 | 0.070 |
Why?
|
| Models, Biological | 2 | 2018 | 1192 | 0.070 |
Why?
|
| Mice, Knockout | 3 | 2019 | 2157 | 0.070 |
Why?
|
| Cell Cycle Proteins | 2 | 2016 | 402 | 0.070 |
Why?
|
| Chlortetracycline | 1 | 2007 | 1 | 0.070 |
Why?
|
| Streptomycin | 1 | 2007 | 14 | 0.070 |
Why?
|
| Boron Compounds | 1 | 2007 | 22 | 0.070 |
Why?
|
| Tetracycline | 1 | 2007 | 22 | 0.070 |
Why?
|
| Keratinocytes | 2 | 2019 | 72 | 0.070 |
Why?
|
| Minocycline | 1 | 2007 | 28 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2019 | 139 | 0.070 |
Why?
|
| Pregnancy | 3 | 2021 | 2372 | 0.060 |
Why?
|
| Chemistry | 1 | 2006 | 31 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2008 | 417 | 0.060 |
Why?
|
| DNA-Binding Proteins | 2 | 2024 | 1225 | 0.060 |
Why?
|
| Multigene Family | 1 | 2006 | 106 | 0.060 |
Why?
|
| Heart Diseases | 1 | 2008 | 223 | 0.060 |
Why?
|
| Collagen | 2 | 2016 | 135 | 0.060 |
Why?
|
| NADPH Oxidases | 2 | 2016 | 69 | 0.060 |
Why?
|
| Hydrolysis | 1 | 2005 | 147 | 0.060 |
Why?
|
| Trichuris | 1 | 2024 | 10 | 0.060 |
Why?
|
| Nematode Infections | 1 | 2024 | 10 | 0.050 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2024 | 12 | 0.050 |
Why?
|
| Cisplatin | 1 | 2025 | 145 | 0.050 |
Why?
|
| Acetyl Coenzyme A | 2 | 2017 | 23 | 0.050 |
Why?
|
| Ancylostoma | 1 | 2024 | 28 | 0.050 |
Why?
|
| Nematoda | 1 | 2024 | 32 | 0.050 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2024 | 24 | 0.050 |
Why?
|
| Carcinogenesis | 2 | 2015 | 135 | 0.050 |
Why?
|
| Amidohydrolases | 1 | 2024 | 36 | 0.050 |
Why?
|
| Rats | 1 | 2007 | 1994 | 0.050 |
Why?
|
| Thyroid Hormones | 1 | 2024 | 81 | 0.050 |
Why?
|
| Tubulin | 1 | 2024 | 73 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2023 | 116 | 0.050 |
Why?
|
| Cytoskeleton | 1 | 2024 | 141 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2006 | 742 | 0.050 |
Why?
|
| Dextran Sulfate | 2 | 2015 | 39 | 0.050 |
Why?
|
| Prodrugs | 1 | 2003 | 36 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2014 | 47 | 0.050 |
Why?
|
| Affinity Labels | 1 | 2022 | 10 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2023 | 102 | 0.050 |
Why?
|
| Xanthones | 1 | 2022 | 6 | 0.050 |
Why?
|
| Microtubules | 1 | 2024 | 210 | 0.050 |
Why?
|
| Fibrinogen | 1 | 2022 | 33 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2016 | 374 | 0.050 |
Why?
|
| Aminoglycosides | 1 | 2002 | 11 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2022 | 117 | 0.050 |
Why?
|
| Profilins | 1 | 2022 | 44 | 0.050 |
Why?
|
| RNA, Small Interfering | 3 | 2016 | 981 | 0.050 |
Why?
|
| Myxovirus Resistance Proteins | 1 | 2021 | 5 | 0.040 |
Why?
|
| Enterovirus D, Human | 1 | 2021 | 11 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2023 | 435 | 0.040 |
Why?
|
| Progestins | 1 | 2021 | 29 | 0.040 |
Why?
|
| S100 Proteins | 1 | 2021 | 20 | 0.040 |
Why?
|
| Vero Cells | 1 | 2021 | 81 | 0.040 |
Why?
|
| Endometrium | 1 | 2021 | 31 | 0.040 |
Why?
|
| Hydrogen Bonding | 1 | 2021 | 128 | 0.040 |
Why?
|
| Smoke | 1 | 2021 | 24 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 169 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2022 | 222 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2021 | 94 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2022 | 218 | 0.040 |
Why?
|
| Static Electricity | 1 | 2021 | 170 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2021 | 61 | 0.040 |
Why?
|
| Caspases, Initiator | 1 | 2020 | 9 | 0.040 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2021 | 55 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 896 | 0.040 |
Why?
|
| Cholesterol | 1 | 2022 | 261 | 0.040 |
Why?
|
| Citric Acid Cycle | 1 | 2020 | 29 | 0.040 |
Why?
|
| Stromal Interaction Molecule 1 | 1 | 2020 | 6 | 0.040 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2020 | 39 | 0.040 |
Why?
|
| Prolactin | 1 | 2020 | 40 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2020 | 115 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2020 | 301 | 0.040 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2019 | 11 | 0.040 |
Why?
|
| DNA Damage | 2 | 2015 | 297 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2020 | 526 | 0.040 |
Why?
|
| Caspases | 1 | 2020 | 176 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 115 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 287 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 80 | 0.040 |
Why?
|
| HMGA Proteins | 1 | 2018 | 5 | 0.040 |
Why?
|
| Prolactinoma | 1 | 2018 | 4 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 279 | 0.040 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2018 | 9 | 0.040 |
Why?
|
| Pituitary Neoplasms | 1 | 2018 | 21 | 0.040 |
Why?
|
| Histone Code | 1 | 2018 | 25 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2020 | 221 | 0.030 |
Why?
|
| Cathelicidins | 1 | 2018 | 11 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2018 | 83 | 0.030 |
Why?
|
| Survival Rate | 1 | 2020 | 844 | 0.030 |
Why?
|
| Cats | 1 | 2018 | 89 | 0.030 |
Why?
|
| RAW 264.7 Cells | 1 | 2018 | 50 | 0.030 |
Why?
|
| Nigericin | 1 | 2017 | 4 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2017 | 29 | 0.030 |
Why?
|
| Calcimycin | 1 | 2017 | 19 | 0.030 |
Why?
|
| Streptococcus | 1 | 2017 | 19 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2017 | 62 | 0.030 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2017 | 41 | 0.030 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2019 | 263 | 0.030 |
Why?
|
| Climate | 1 | 2017 | 8 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 72 | 0.030 |
Why?
|
| Transglutaminases | 1 | 2017 | 14 | 0.030 |
Why?
|
| Biological Transport | 1 | 2018 | 292 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2017 | 68 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 84 | 0.030 |
Why?
|
| Organoids | 1 | 2017 | 41 | 0.030 |
Why?
|
| Phosphofructokinase-2 | 1 | 2016 | 1 | 0.030 |
Why?
|
| Candida albicans | 1 | 2017 | 61 | 0.030 |
Why?
|
| Dogs | 1 | 2018 | 315 | 0.030 |
Why?
|
| Anti-Citrullinated Protein Antibodies | 1 | 2016 | 7 | 0.030 |
Why?
|
| Luteinizing Hormone, beta Subunit | 1 | 2016 | 3 | 0.030 |
Why?
|
| Estrous Cycle | 1 | 2016 | 12 | 0.030 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 43 | 0.030 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2016 | 30 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 15 | 0.030 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2016 | 10 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 89 | 0.030 |
Why?
|
| NADPH Oxidase 2 | 1 | 2016 | 36 | 0.030 |
Why?
|
| Respiratory Burst | 1 | 2016 | 21 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2016 | 167 | 0.030 |
Why?
|
| STAT5 Transcription Factor | 1 | 2016 | 14 | 0.030 |
Why?
|
| Janus Kinase 2 | 1 | 2016 | 21 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 235 | 0.030 |
Why?
|
| Agar | 1 | 2015 | 4 | 0.030 |
Why?
|
| Sepharose | 1 | 2015 | 7 | 0.030 |
Why?
|
| Transcriptome | 1 | 2018 | 399 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2016 | 324 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 128 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 237 | 0.030 |
Why?
|
| Carcinoma in Situ | 1 | 2015 | 36 | 0.030 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2015 | 44 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 2015 | 96 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2015 | 104 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2018 | 641 | 0.030 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2014 | 10 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 2014 | 45 | 0.030 |
Why?
|
| Adult | 3 | 2017 | 17358 | 0.030 |
Why?
|
| Central Nervous System Bacterial Infections | 1 | 2014 | 3 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2016 | 574 | 0.030 |
Why?
|
| Middle Aged | 3 | 2017 | 18273 | 0.030 |
Why?
|
| Brain Infarction | 1 | 2014 | 21 | 0.030 |
Why?
|
| Psoriasis | 1 | 2015 | 59 | 0.030 |
Why?
|
| L-Selectin | 1 | 2014 | 14 | 0.030 |
Why?
|
| Sinus of Valsalva | 1 | 2014 | 7 | 0.030 |
Why?
|
| Tunica Intima | 1 | 2014 | 16 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 108 | 0.030 |
Why?
|
| Extracellular Space | 1 | 2014 | 29 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 1008 | 0.030 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2014 | 53 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2014 | 241 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2014 | 213 | 0.030 |
Why?
|
| Histone Acetyltransferases | 2 | 2004 | 59 | 0.030 |
Why?
|
| Skin | 1 | 2017 | 422 | 0.020 |
Why?
|
| Neutropenia | 1 | 2014 | 68 | 0.020 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2013 | 7 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 2014 | 101 | 0.020 |
Why?
|
| Endothelium | 1 | 2013 | 21 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2014 | 300 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2014 | 115 | 0.020 |
Why?
|
| Aortic Diseases | 1 | 2014 | 65 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2013 | 70 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 211 | 0.020 |
Why?
|
| Vasodilation | 1 | 2013 | 36 | 0.020 |
Why?
|
| Cyclin D | 1 | 2013 | 4 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 662 | 0.020 |
Why?
|
| Autoantigens | 1 | 2014 | 139 | 0.020 |
Why?
|
| Cyclin E | 1 | 2013 | 14 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2013 | 12 | 0.020 |
Why?
|
| Epitopes | 1 | 2014 | 291 | 0.020 |
Why?
|
| G1 Phase | 1 | 2013 | 58 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 542 | 0.020 |
Why?
|
| Cell Death | 1 | 2014 | 289 | 0.020 |
Why?
|
| Response Elements | 1 | 2012 | 44 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 237 | 0.020 |
Why?
|
| Time Factors | 1 | 2020 | 3762 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2012 | 29 | 0.020 |
Why?
|
| Nanotubes, Carbon | 1 | 2012 | 19 | 0.020 |
Why?
|
| Nucleotide Motifs | 1 | 2012 | 52 | 0.020 |
Why?
|
| N-Terminal Acetyltransferase E | 1 | 2012 | 1 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2012 | 185 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2013 | 541 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 465 | 0.020 |
Why?
|
| Estrogens | 1 | 2012 | 115 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2012 | 85 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2011 | 46 | 0.020 |
Why?
|
| HT29 Cells | 1 | 2011 | 28 | 0.020 |
Why?
|
| Collagen Type II | 1 | 2011 | 12 | 0.020 |
Why?
|
| Stem Cells | 1 | 2013 | 276 | 0.020 |
Why?
|
| Lipids | 1 | 2014 | 328 | 0.020 |
Why?
|
| Peptides, Cyclic | 1 | 2011 | 23 | 0.020 |
Why?
|
| Synovial Membrane | 1 | 2011 | 21 | 0.020 |
Why?
|
| Microglia | 1 | 2014 | 250 | 0.020 |
Why?
|
| Oocytes | 1 | 2012 | 201 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 301 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 281 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 297 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2011 | 371 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 1233 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 361 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 794 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 4809 | 0.020 |
Why?
|
| Manganese Compounds | 1 | 2008 | 8 | 0.020 |
Why?
|
| DNA Footprinting | 1 | 2008 | 18 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2008 | 28 | 0.020 |
Why?
|
| Oxides | 1 | 2008 | 36 | 0.020 |
Why?
|
| Glycomics | 1 | 2007 | 4 | 0.020 |
Why?
|
| RNA Polymerase II | 1 | 2008 | 86 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2008 | 152 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2008 | 146 | 0.020 |
Why?
|
| Age Factors | 1 | 2011 | 1586 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 405 | 0.020 |
Why?
|
| Risk Factors | 1 | 2016 | 5429 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2008 | 398 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 1559 | 0.010 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2004 | 12 | 0.010 |
Why?
|
| Mitochondria | 1 | 2008 | 410 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 14965 | 0.010 |
Why?
|